Non-cell-autonomous stimulation of stem cell proliferation following ablation of Tcf3

Experimental Cell Research

Volumn 316, Issue 6, 2010, Pages 1050-1060

  Yi, Fei ^a   Merrill, Bradley J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Embryonic stem cell; Stat3; Tcf3; Wnt

Indexed keywords

BETA CATENIN; JANUS KINASE; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR; STAT3 PROTEIN; T CELL FACTOR PROTEIN; TCF3 PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL CELL; ARTICLE; CANCER STEM CELL; CELL PROLIFERATION; CELL RENEWAL; COCULTURE; CONTROLLED STUDY; EMBRYONIC STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TUMOR GROWTH; UPREGULATION;

EID: 77649187042     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2009.12.005     Document Type: Article

References (33)

1. Nusse R. Wnt signaling and stem cell control. Cell Res. 18 (2008) 523-527
2. Brannon M., Gomperts M., Sumoy L., Moon R.T., and Kimelman D. A beta-catenin/XTcf-3 complex binds to the siamois promoter to regulate dorsal axis specification in Xenopus. Genes Dev. 11 (1997) 2359-2370
3. Molenaar M., van de Wetering M., Oosterwegel M., Peterson-Maduro J., Godsave S., Korinek V., Roose J., Destree O., and Clevers H. XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 86 (1996) 391-399
4. van de Wetering M., Cavallo R., Dooijes D., van Beest M., van Es J., Loureiro J., Ypma A., Hursh D., Jones T., Bejsovec A., Peifer M., Mortin M., and Clevers H. Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell 88 (1997) 789-799
5. Tutter A.V., Fryer C.J., and Jones K.A. Chromatin-specific regulation of LEF-1-beta-catenin transcription activation and inhibition in vitro. Genes Dev. 15 (2001) 3342-3354
6. Willert K., and Jones K.A. Wnt signaling: is the party in the nucleus?. Genes Dev. 20 (2006) 1394-1404
7. Reya T., Duncan A.W., Ailles L., Domen J., Scherer D.C., Willert K., Hintz L., Nusse R., and Weissman I.L. A role for Wnt signaling in self-renewal of haematopoietic stem cells. Nature 423 (2003) 409-414
8. Gat U., DasGupta R., Degenstein L., and Fuchs E. De novo hair follicle morphogenesis and hair tumors in mice expressing a truncated beta-catenin in skin. Cell 95 (1998) 605-614
9. Korinek V., Barker N., Moerer P., van Donselaar E., Huls G., Peters P.J., and Clevers H. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat. Genet. 19 (1998) 379-383
10. Sato T., Vries R.G., Snippert H.J., van de Wetering M., Barker N., Stange D.E., van Es J.H., Abo A., Kujala P., Peters P.J., and Clevers H. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459 (2009) 262-265
11. Sato N., Meijer L., Skaltsounis L., Greengard P., and Brivanlou A.H. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat. Med. 10 (2004) 55-63
12. Morin P.J. beta-Catenin signaling and cancer. BioEssays 21 (1999) 1021-1030
13. Barker N., Ridgway R.A., van Es J.H., van de Wetering M., Begthel H., van den Born M., Danenberg E., Clarke A.R., Sansom O.J., and Clevers H. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457 (2009) 608-611
14. Peerani R., Onishi K., Mahdavi A., Kumacheva E., and Zandstra P.W. Manipulation of signaling thresholds in "engineered stem cell niches" identifies design criteria for pluripotent stem cell screens. PLoS ONE 4 (2009) e6438
15. Williams R.L., Hilton D.J., Pease S., Willson T.A., Stewart C.L., Gearing D.P., Wagner E.F., Metcalf D., Nicola N.A., and Gough N.M. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336 (1988) 684-687
16. Smith A.G., Heath J.K., Donaldson D.D., Wong G.G., Moreau J., Stahl M., and Rogers D. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 336 (1988) 688-690
17. Ying Q.L., Wray J., Nichols J., Batlle-Morera L., Doble B., Woodgett J., Cohen P., and Smith A. The ground state of embryonic stem cell self-renewal. Nature 453 (2008) 519-523
18. Yi F., Pereira L., and Merrill B.J. Tcf3 functions as a steady state limiter of transcriptional programs of mouse embryonic stem cell self renewal. Stem Cells (2008)
19. Cole M.F., Johnstone S.E., Newman J.J., Kagey M.H., and Young R.A. Tcf3 is an integral component of the core regulatory circuitry of embryonic stem cells. Genes Dev. 22 (2008) 746-755
20. Tam W.L., Lim C.Y., Han J., Zhang J., Ang Y.S., Ng H.H., Yang H., and Lim B. Tcf3 regulates embryonic stem cell pluripotency and self-renewal by the transcriptional control of multiple lineage pathways. Stem Cells (2008)
21. Pereira L., Yi F., and Merrill B.J. Repression of Nanog gene transcription by tcf3 limits embryonic stem cell self-renewal. Mol. Cell. Biol. 26 (2006) 7479-7491
22. Meydan N., Grunberger T., Dadi H., Shahar M., Arpaia E., Lapidot Z., Leeder J.S., Freedman M., Cohen A., Gazit A., Levitzki A., and Roifman C.M. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 379 (1996) 645-648
23. Wang L.H., Kirken R.A., Erwin R.A., Yu C.R., and Farrar W.L. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response. J. Immunol. 162 (1999) 3897-3904
24. Pedranzini L., Dechow T., Berishaj M., Comenzo R., Zhou P., Azare J., Bornmann W., and Bromberg J. Pyridone 6, a pan-Janus-activated kinase inhibitor, induces growth inhibition of multiple myeloma cells. Cancer Res. 66 (2006) 9714-9721
25. Fairlie W.D., Uboldi A.D., McCoubrie J.E., Wang C.C., Lee E.F., Yao S., De Souza D.P., Mifsud S., Metcalf D., Nicola N.A., Norton R.S., and Baca M. Affinity maturation of leukemia inhibitory factor and conversion to potent antagonists of signaling. J. Biol. Chem. 279 (2004) 2125-2134
26. Merrill B.J., Pasolli H.A., Polak L., Rendl M., Garcia-Garcia M.J., Anderson K.V., and Fuchs E. Tcf3: a transcriptional regulator of axis induction in the early embryo. Development 131 (2004) 263-274
27. Houston D.W., Kofron M., Resnik E., Langland R., Destree O., Wylie C., and Heasman J. Repression of organizer genes in dorsal and ventral Xenopus cells mediated by maternal XTcf3. Development 129 (2002) 4015-4025
28. Kim C.H., Oda T., Itoh M., Jiang D., Artinger K.B., Chandrasekharappa S.C., Driever W., and Chitnis A.B. Repressor activity of headless/Tcf3 is essential for vertebrate head formation. Nature 407 (2000) 913-916
29. Al Zaid Siddiquee K., and Turkson J. STAT3 as a target for inducing apoptosis in solid and hematological tumors. Cell Res. 18 (2008) 254-267
30. Hong D.S., Angelo L.S., and Kurzrock R. Interleukin-6 and its receptor in cancer: implications for translational therapeutics. Cancer 110 (2007) 1911-1928
31. Chung Y.C., and Chang Y.F. Serum interleukin-6 levels reflect the disease status of colorectal cancer. J. Surg. Oncol. 83 (2003) 222-226
32. Corvinus F.M., Orth C., Moriggl R., Tsareva S.A., Wagner S., Pfitzner E.B., Baus D., Kaufmann R., Huber L.A., Zatloukal K., Beug H., Ohlschlager P., Schutz A., Halbhuber K.J., and Friedrich K. Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth. Neoplasia 7 (2005) 545-555
33. Baltgalvis K.A., Berger F.G., Pena M.M., Davis J.M., Muga S.J., and Carson J.A. Interleukin-6 and cachexia in ApcMin/+ mice. Am. J. Physiol., Regul. Integr. Comp. Physiol. 294 (2008) R393-401